The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Krivosheev A.B.

GBOU VPO "Novosibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF

Kuimov A.D.

Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk Russia

Bogoryanova P.A.

Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk Russia

Kondratova M.A.

GBOU VPO "Novosibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF

Kupriianova L.Ia.

GBUZ "Gosudarstvennyĭ novosibirskiĭ oblastnoĭ klinicheskiĭ diagnosticheskiĭ tsentr"

Popov K.V.

Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk Russia

Tuguleva T.A.

Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk Russia

Clinical and metabolic features of nonalcoholic fatty liver disease in men and women

Authors:

Krivosheev A.B., Kuimov A.D., Bogoryanova P.A., Kondratova M.A., Kupriianova L.Ia., Popov K.V., Tuguleva T.A.

More about the authors

Journal: Therapeutic Archive. 2017;89(2): 45‑51

DOI: 10.17116/terarkh201789245-51

Read: 2602 times

Download PDF (RU)
Contact the author
Table of contents

CLINICAL AND METABOLIC FEATURES OF NONALCOHOLIC FATTY LIVER DISEASE IN MEN AND WOMEN
CLINICAL AND METABOLIC FEATURES OF NONALCOHOLIC FATTY LIVER DISEASE IN MEN AND WOMEN

To cite this article:

Krivosheev AB, Kuimov AD, Bogoryanova PA, Kondratova MA, Kupriianova LIa, Popov KV, Tuguleva TA. Clinical and metabolic features of nonalcoholic fatty liver disease in men and women. Therapeutic Archive. 2017;89(2):45‑51. (In Russ.)
https://doi.org/10.17116/terarkh201789245-51

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Effe­ctiveness of using preventive and personalized technologies for obesity correction. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):80-90
A case of Becker muscular dystrophy in a woman with skewed X-chromosome inactivation. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):139-144
Clinical and anamnestic features of rosa­cea in women in peri­menopausal period. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):49-55
The Rela­tionship of obstructive sleep apnea with paro­xysmal atrial fibrillation in women suffered coro­nary heart disease and arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(2):61-66
Coro­navirus infe­ction as a risk factor in occlusive-stenotic lesions of the brachiocephalic arte­ries. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):44-52
Prevalence and role of elevated serum lipo­protein(a) in patients with myocardial infa­rction acco­rding to the Russian regi­ster of acute myocardial infa­rction REGION-MI. Russian Cardiology Bulletin. 2025;(1):39-48
Modern aspe­cts of gestational diabetes mellitus: defi­nition, risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):35-41
The expe­rience of using the drug Pineamin to improve the quality of ejaculate and reduce the symptoms asso­ciated with male aging. Russian Journal of Human Reproduction. 2025;(2):101-108
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
Dyna­mics of the nature of labor and its asso­ciation with health self-assessment in men working in expe­ditional shift mode in Arctic conditions. Russian Journal of Preventive Medi­cine. 2025;(5):14-20
Abstract:

Aim. To evaluate clinical features and metabolic disorders in men and women with non-alcoholic fatty liver disease (NAFLD).

Keywords:

nonalcoholic fatty liver disease
men
women
dyslipidemia
insulin resistance
porphyrin metabolism

Authors:

Krivosheev A.B.

GBOU VPO "Novosibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF

Kuimov A.D.

Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk Russia

Bogoryanova P.A.

Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk Russia

Kondratova M.A.

GBOU VPO "Novosibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF

Kupriianova L.Ia.

GBUZ "Gosudarstvennyĭ novosibirskiĭ oblastnoĭ klinicheskiĭ diagnosticheskiĭ tsentr"

Popov K.V.

Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk Russia

Tuguleva T.A.

Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk Russia

Close metadata

References:

  1. McCullough AJ. The epidemiology and risk factors of NASH. In: Fatty Liver Disease: NASH and related Disorders. GC Farrell, J George, P Hall, AJ McCullough (eds.). Oxford: Blackwell, 2005:23-37.
  2. Alwis de NMW, Day CP. Nonalcoholic fatty liver disease:the mist gradually clears. J Hepatology 2008;48(1):104-112.
  3. Browning JD, Szczepaniak LS, Dobbins R, Nurenberg P, Horton JD, Cohen JC, Grundy SH, Hobbs HH. Prevalence of hepatic cteatosis in an urban population in the United States: Impact of ethnicity. Hepatology. 2004;40(6):1387-1395.
  4. Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988—1994. Am J Epidemiol. 2013;178(1):38-45. doi:10.1093/aje/kws448
  5. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, Cristanini G, Tiribelli C et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy. Ann Intern Med. 2000;132(2):112-117.
  6. Fan JG, Farrell GC. Epidemiology of nonalcoholic fatty liver disease in China. J Hepatol. 2009;50:204-210.
  7. Wong VW, Chu WC, Wong GL-H, Chan RS-M, Chm AM-L, Ong A et al. Prevalence of nonalcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Radiology. 2012;61(3):409-415.
  8. Hashimoto E, Tokushigie K. Prevalence, gender, ethnic, and prognosis of NASH. J Gastroenterol. 2011;46(1):63-69.
  9. Park S, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK. Prevalence and factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006;21(1):138-143.
  10. Ivashkin VT, Drapkina OM. The prevalence of non-alcoholic fatty liver disease in Russian Federation. UEGW/WCOG GASTRO 2009;Nov. 21-25. London, 2009:1207.
  11. Nedogoda SV, Savina TN, Pocheptsov DA. Nonalcoholic fatty liver disease. Bulletin of Volgograd State Medical University. 2009;3(31):3-11. (in Russ.).
  12. Caldwell SG, Al-Uthaymeen OMS, Argo KK. Nonalcoholic fatty liver disease. Proc. Schiff YR, Sorrell MF, Meddrey US. Diseases of the liver Schiff. Alcohol, drugs, genetic and metabolic diseases. Moscow; GEOTAR-Media. 2011:393-446 (in Russ.).
  13. Bedogni G, Miglioli L, Masutti F, Tiribelli C. Prevalence and risk factors for non-alcoholic fatty liver disease:the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44-52.
  14. Ivashkin VT, Drapkina OM, ON Korneev Clinical variants of metabolic syndrome. Moscow. Medical News Agency. 2011 (in Russ.).
  15. Diagnosis and treatment of nonalcoholic fatty liver disease. Ed. Acad. Academy of Medical Sciences, Professor. VT Ivashkina. Moscow: MEDpress. 2012 (in Russ.).
  16. Targer G, Day PD, Bonora EN. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease. Engl J Med. 2010;363:1341-1350.
  17. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease:A global perspective. Semin Liver Dis. 2008;28:339-350.
  18. Cope MB, Allison DB. Obesity:person and population. Obesity. 2006;14(Suppl.4):156-159.
  19. Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCoullough A. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin. Gastroenterol. Hepatol. 2004;2(3):262-265.
  20. Vernon G, Baranova A, Younosi ZM. Systematic review:the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol. Ther. 2011;34(2):274-285.
  21. McLeay SC, Morrish GA, Ponnuswamy TK, Devanand B, Ramanathan M, Venkatakrishnan L, Ramalingam S, Green B. Noninvasive Quantification of Hepatic Steatosis:Relationship Between Obesity Status and Liver Fat Content. Open Obesity Journal. 2014;6 (1):16-24. doi:10.2174/1876823701406010016
  22. Ivashkin VT, Drapkina OM. Recommendations on the diagnosis and therapy non-alcoholic fatty liver diseases. Science advice therapy RF. Moscow: 2012. (in Russ.).
  23. Borman MA, Ladak F, Crotti P, Pollett A, Kirsch R, Pomier-Layrargues G Beaton M,·Duarte-Rojo A, Elkashab M, Myers RP. The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients. Hepatology International. 2013;7(6):592-599. doi:10.1007/s12072-012-9401-4
  24. Balabolkin MI, Klebanova VM, Kreminskay VM. New classification, criterions diagnosis and compensation of diabetes mellitus. Terapevtichekiy arkhiv. 2000;72(10):5-10. (In Russ.).
  25. Algoritm specialization medical help for patients with diabetes mellitus. Edd. by II Dedov, MI Shestakova. Moscow: 2013 (In Russ.).
  26. Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994;15:1300-1331. GL.
  27. Aronov DM, Arabidze CG, Akhmedzhanov NM, Balahjnova TV, Boytsov SA, Bubnova MC et al. Diagnostics and correction of lipid disorders for prevention and treatment of atherosclerosis. Rossiyskiye rekomendatsii V peresmotr. Moscow; 2012. (In Russ.)
  28. Yahontov DA. Evidence-based medicine in questions and answers. Novosibirsk, 2012. (in Russ.).
  29. Tarasova OI, Ogurtsov AP. Modern laboratory markers of alcohol use. Clinical Pharmacology and Therapeutics. 2007;16(1):10-15 (in Russ.).
  30. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221-1231.
  31. Gmyza OA. Status porphyrin metabolism in non-alcoholic fatty liver disease. Author. Dis. MD ... Novosibirsk, 2013.
  32. Krivosheev AB, Kuimov AD, Peskov SA, Krivosheeva IA, Paul GA. Porphyrin metabolism in men with metabolic syndrome. Clinichskya meditsina. 2006;84(11):57-60 (in Russ.).
  33. Krivosheev AB, Kuimov AD, Krivosheeva IA, Gmyza OA. Metabolic disturbances on the patients with non-alcoholic steatohepatitis. Bulleten SD RAMS. 2007;6:91-98. (in Russ.).
  34. Pisanez M, Pavlov P. Diabetes mellitus and porphyrins biosintesis. Problemy endocrinollogii 1983;29(1):11-15 (in Russ.).
  35. Sixel-Dietrich F, Verspohl F. Hyperinsulinemia in acute intermittent porphyria. Hormone Metabol. 1985;17(3):375-376.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.